Speaker
Hongzhou Huasai Biomedicine
Zhang Changfeng, Hongzhou Huasai Biomedicine, is speaking at 8th TIL Therapies Summit 2026 (Boston, United States of America, 17–19 Nov 2026) in the session “Building Robust Manufacturing & Quality Systems to Enable the Commercialization of TIL Therapies”.
17–19 Nov 2026Boston, United States of America
CuraCell Holding AB
CTMC
Texas Tech University Health Sciences Center
University of Colorado
NEOGAP Therapeutics AB
Stanford University
This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Zhang Changfeng, and it lists only the talks, sessions and presentations named in those programmes.
Is this you? Claim this profile — every request is read by a person before anything is linked.
To ask for a correction or for this profile to be removed, email [email protected].